Get the Stockscreener App
29.69
0.37%
0.11
After Hours:
29.41
-0.28
-0.94%
Amrep Corp stock is traded at $29.69, with a volume of 5,662.
It is up +0.37% in the last 24 hours and up +36.51% over the past month.
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
See More
Previous Close:
$29.58
Open:
$29.6
24h Volume:
5,662
Relative Volume:
0.26
Market Cap:
$157.53M
Revenue:
$44.53M
Net Income/Loss:
$2.23M
P/E Ratio:
7.4411
EPS:
3.99
Net Cash Flow:
$10.87M
1W Performance:
-3.20%
1M Performance:
+36.51%
6M Performance:
+27.75%
1Y Performance:
+76.49%
1-Day Range:
$29.41
$30.02
1-Week Range:
$28.75
$31.26
52-Week Range:
$15.38
$31.26
Amrep Corp Stock (AXR) Company Profile
Name
Amrep Corp
Sector
Industry
Phone
610-487-0905
Address
850 WEST CHESTER PIKE, HAVERTOWN, PA
Amrep Corp Stock (AXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-07 | Upgrade | Matrix Research | Hold → Buy |
| Jan-17-07 | Downgrade | Matrix Research | Buy → Hold |
Amrep Corp Stock (AXR) Latest News
AMREP Co. (NYSE:AXR) Major Shareholder James H. Dahl Buys 2,000 Shares - MarketBeat
Amrep corp insider buys shares worth nearly $60k By Investing.com - Investing.com South Africa
Amrep corp insider buys shares worth nearly $60k By Investing.com - Investing.com Canada
Amrep corp insider buys shares worth nearly $60k - Investing.com
Amgen stock slides 5% as analysts weigh in on drug study results (update) - Seeking Alpha
Amgen’s stock falls 4% as analysts say drug updates lag competitors - MarketWatch
Amgen Stock Falls on Disappointing Drug Data - The Wall Street Journal
AMREP Corp Stock Soars to 52-Week High of $31.19 Amidst Strong Growth - Investing.com
Amgen falls after reporting mixed data on two drugs - XM
Check out these key findings about Amylyx Pharmaceuticals Inc (AMLX) - SETE News
A-Mark Precious Metals, Inc. (NASDAQ:AMRK) Announces Quarterly Dividend of $0.20 - MarketBeat
Analyzing Ratios: Amylyx Pharmaceuticals Inc (AMLX)’s Financial Story Unveiled - The Dwinnex
Amarin Corp ADR (AMRN) stock analysis: A comprehensive overview - US Post News
1,881 Shares in Alpha Metallurgical Resources, Inc. (NYSE:AMR) Acquired by XTX Topco Ltd - Defense World
Epoch Investment Partners Inc. Sells 1,213,043 Shares of Amcor plc (NYSE:AMCR) - Defense World
XTX Topco Ltd Takes $453,000 Position in Ameresco, Inc. (NYSE:AMRC) - MarketBeat
American Century Companies Inc. Boosts Stake in Ameresco, Inc. (NYSE:AMRC) - Defense World
State of New Jersey Common Pension Fund D Decreases Position in Alpha Metallurgical Resources, Inc. (NYSE:AMR) - Defense World
A-Mark Precious Metals, Inc. (NASDAQ:AMRK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
A-Mark Precious Metals (NASDAQ:AMRK) Rating Increased to Hold at StockNews.com - Defense World
Amgen stock slips 3% following Phase 3 data for rocatinlimab, Uplizna (NASDAQ:AMGN) - Seeking Alpha
Amrep Corp insider buys $92,250 in company stock By Investing.com - Investing.com South Africa
Amrep Corp insider buys $92,250 in company stock By Investing.com - Investing.com Australia
Amrep Corp insider buys $92,250 in company stock By Investing.com - Investing.com Canada
Amrep Corp insider buys $92,250 in company stock - Investing.com
Amrep Corp insider buys $92,250 in company stock - Investing.com India
Amrep Corp insider buys $92,250 in company stock By Investing.com - Investing.com UK
A-Mark Precious Metals director sells over $2.6m in company stock - Investing.com
Ratio Analysis: Unpacking America Movil S.A.B.DE C.V. ADR (AMX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Alpha Metallurgical Resources (NYSE:AMR) Shares Up 8.1% - MarketBeat
Insider Move: GREGORY ROBERTS Exercises Options, Realizing $493K At A-Mark Precious Metals - Benzinga
A year in review: Amylyx Pharmaceuticals Inc (AMLX)’s performance in the last year - US Post News
Amgen gets early win in Regeneron lawsuit over Eylea biosimilar - Reuters
Intech Investment Management LLC Purchases 124,547 Shares of Amcor plc (NYSE:AMCR) - Defense World
AE Wealth Management LLC Buys 8,763 Shares of Amcor plc (NYSE:AMCR) - Defense World
Hsbc Holdings PLC Sells 226,786 Shares of Amcor plc (NYSE:AMCR) - MarketBeat
Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea - Investor's Business Daily
A-Mark Precious Metals, Inc. (NASDAQ:AMRK) CEO Gregory N. Roberts Sells 4,320 Shares - MarketBeat
It is Poised to be a Bull Market for Ameris Bancorp (ABCB) - SETE News
Alpha Metallurgical Resources Inc (AMR) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
A Guide To The Risks Of Investing In Amylyx Pharmaceuticals Inc (AMLX) - Knox Daily
Frank Rimerman Advisors LLC Makes New Investment in Amcor plc (NYSE:AMCR) - Defense World
The growth track for Ameresco Inc. (AMRC) has changed recently - SETE News
ProShare Advisors LLC Boosts Stock Position in Amcor plc (NYSE:AMCR) - Defense World
Ameresco, Inc. (NYSE:AMRC) Shares Sold by DekaBank Deutsche Girozentrale - Defense World
Delap Wealth Advisory LLC Purchases Shares of 23,338 Amcor plc (NYSE:AMCR) - Defense World
Amalgamated Bank Raises Holdings in Amcor plc (NYSE:AMCR) - Defense World
Dimensional Fund Advisors LP Grows Position in Amcor plc (NYSE:AMCR) - Defense World
Rhumbline Advisers Has $1.48 Million Holdings in Ameresco, Inc. (NYSE:AMRC) - Defense World
Acadian Asset Management LLC Purchases Shares of 7,699 Amcor plc (NYSE:AMCR) - Defense World
Sompo Asset Management Co. Ltd. Decreases Stake in Amcor plc (NYSE:AMCR) - Defense World
Amrep Corp Stock (AXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
3.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):